A Multicenter, Randomized, Double-Blind, Placebo-Controlled Induction Study to Evaluate the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects with Moderately to Severely Active Ulcerative Colitis

Project: Research

Project Description

NMA HREC Reference Number: HREC/50863/SVHM-2019-176966(v2)
NMA SSA Reference Number: SSA/50863/MonH-2019-176584(v1)
Monash Health Ref: RES-19-0000-418X
Effective start/end date17/07/1916/07/24


  • Clinical trial
  • colitis
  • treatment efficacy
  • treatment safety